Skip to content

Effectiveness of Shock Wave Therapy Versus Low Level Lazer Therapy in Diabetic Frozen Shoulder Patients.

Effectiveness of Shock Wave Therapy Versus Low Level Lazer Therapy in Diabetic

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05967923
Enrollment
40
Registered
2023-08-01
Start date
2023-07-05
Completion date
2024-11-15
Last updated
2023-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Complications

Keywords

Diabetes, Frozen shoulder

Brief summary

Patients will be divided randomly into 3 groups.

Detailed description

Patients will be allocated from out patient clinics of Qena university hospitals Then they will be randomly assigned to three groups, every one will contain 30 patients of both gender, with age range between 45 and 60 years old

Interventions

RADIATIONShock wave therapy

Patients in this group will receive shock wave therapy once a week for four weeks in addition to routine physical therapy program.

Patients in this group will receive low level lazer therapy three times a week week for four weeks in addition to routine physical therapy program.

Patients in this group will receive only routine physical therapy program three times a week for four weeks.

Sponsors

South Valley University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Group (a) Group (b) Group (c)

Eligibility

Sex/Gender
ALL
Age
45 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* patients with diabetes mellitus. * patients with frozen shoulder due to diabetes mellitus. * patients age ranged between 45 and 60 years old. * cooperative patients.

Exclusion criteria

* patients with un-controlled hypertension. * patients sensetive to shock wave or lazer irradiation. * Patients with infectious skin diseases. * un-cooperative patients.

Design outcomes

Primary

MeasureTime frameDescription
Shoulder joint Pain4 weeksBy using visual analogue scale
Range of motion of the shoulder4 weeksRange of shoulder internal and external rotation and shoulder flexion

Secondary

MeasureTime frameDescription
Shoulder and hand disability4 weeksBy using quick DASH questionnaire

Countries

Egypt

Contacts

Primary ContactShymaa Yussuf Abo zaid
shaymaayoussef397@gmail.com01010941685

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026